News Affimed N.V.

Equities

AFMD

NL0015001ZQ0

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
4.88 ^USD	-8.79%		-6.69%	-21.92%

Apr. 01	Wells Fargo Cuts Affimed Price Target to $25 From $30, Maintains Overweight Rating	MT
Apr. 01	HC Wainwright Adjusts Affimed's Price Target to $10 From $50, Maintains Buy Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology	Apr. 24	AQ
Wells Fargo Cuts Affimed Price Target to $25 From $30, Maintains Overweight Rating	Apr. 01	MT
HC Wainwright Adjusts Affimed's Price Target to $10 From $50, Maintains Buy Rating	Apr. 01	MT
Affimed N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Transcript : Affimed N.V., 2023 Earnings Call, Mar 28, 2024	Mar. 28
Affimed Reports 2023 Financial Results and Operational Progress	Mar. 28	AQ
Affimed N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024	Mar. 21	AQ
Affimed N : Form 6-K	Mar. 11	PU
Affimed Announces 1-for-10 Reverse Stock Split	Mar. 06	AQ
AFFIMED ANNOUNCES LEADERSHIP CHANGE AND ORGANIZATIONAL RESTRUCTURING	Jan. 09	AQ
Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer	Jan. 08	GL
Affimed N.V. Provides Clinical Response Update on AFM24-102 Trial in EGFR-Wildtype Non-Small Cell Lung Cancer	Jan. 08	CI
Affimed Announces Leadership Change and Organizational Restructuring	Jan. 08	AQ
Affimed N.V. Announces CEO Changes	Jan. 08	CI
Affimed N.V. Announces Management Changes	Jan. 08	CI
Sector Update: Health Care Stocks Mixed Late Afternoon	Jan. 03	MT
Sector Update: Health Care Stocks Gain in Afternoon Trading	Jan. 03	MT
Affimed to Sell AbCheck to Ampersand Biomedicines for $6 Million in Cash, Stock; Shares Fall	Jan. 03	MT
Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck	Jan. 03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Affimed N.V.

Equities

AFMD

NL0015001ZQ0

Summary

Filters